What is Xencor's cash & equivalents?

Xencor (XNCR) reported cash & equivalents of $14.17M in Q1 2026.

How has Xencor's cash & equivalents changed year-over-year?

Xencor's cash & equivalents decreased by 64.3% year-over-year, from $39.68M to $14.17M.

What is the long-term trend for Xencor's cash & equivalents?

Over 5 years (2020 to 2025), Xencor's cash & equivalents has grown at a -19.9% compound annual growth rate (CAGR), from $163.54M to $54.07M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Xencor XNCR Cash & Equivalents

Cash & Equivalents at other companies

AmgenAMGN

$559M+10.0%

Regeneron PharmaceuticalsREGN

$2.97B-4.0%

Janux TherapeuticsJANX

$51.83M-29.7%

AbCellera Biologics Inc.ABCL

$102.06M-44.6%

AnaptysBio, Inc.ANAB

$248.47M+152%

Xenon PharmaceuticalsXENE

$545.87M+368%

Other financials

Income statement

See full

Revenue$4.5M-86.2%

Operating income-$77.9M-80.3%

Net income-$128.9M-166%

EPS (diluted)-$1.71-159%

Balance sheet

See full

Total debt$175.2M-21.2%

Total equity$515.6M-19.4%

Total assets$736.8M-18.6%

Cash flow

See full

Operating cash flow-$67.6M-317%

CapEx$610.0K-57.8%

Free cash flow-$68.2M-286%

Valuation

See full

Market cap$1.07B+76.3%

Enterprise value$1.23B+55.9%

P/S11×+6.2×

Profitability

See full

Operating margin-217.9%+425pp

Net margin-177.1%+16.5pp

FCF margin-194%+166pp

Returns & leverage

See full

Return on equity-29.8%-2.7pp

Debt / equity0.3×0.0×

Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xencor's cash & equivalents?: Xencor (XNCR) reported cash & equivalents of $14.17M in Q1 2026.
How has Xencor's cash & equivalents changed year-over-year?: Xencor's cash & equivalents decreased by 64.3% year-over-year, from $39.68M to $14.17M.
What is the long-term trend for Xencor's cash & equivalents?: Over 5 years (2020 to 2025), Xencor's cash & equivalents has grown at a -19.9% compound annual growth rate (CAGR), from $163.54M to $54.07M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.